Boston, MA, United States of America

Matteo Ligorio

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Matteo Ligorio: Innovator in Local Drug Delivery Devices

Introduction

Matteo Ligorio is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of medical technology, particularly in the development of local drug delivery systems aimed at treating cancer. With a total of 2 patents, Ligorio's work is at the forefront of innovative cancer treatment methods.

Latest Patents

Ligorio's latest patents focus on drug-eluting devices and methods for treating tumors in various organs, including the pancreas, biliary system, gallbladder, liver, small bowel, and colon. These patents describe methods for deploying a drug-eluting device that contains a film made from a mixture of a degradable polymer and a chemotherapeutic drug. The film's thickness ranges from about 2 µm to about 1000 µm. The device is designed to release a therapeutically effective amount of the drug to treat tumors, with the release controlled by the in vivo degradation of the polymer at the tissue site.

Career Highlights

Throughout his career, Ligorio has worked with esteemed institutions such as the Massachusetts Institute of Technology and The General Hospital Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field of medical research and innovation.

Collaborations

Some of Ligorio's notable coworkers include Laura Indolfi and Elazer Reuven Edelman. Their collaborative efforts have contributed to advancements in drug delivery technologies and cancer treatment methodologies.

Conclusion

Matteo Ligorio's innovative work in local drug delivery devices represents a significant advancement in cancer treatment. His patents and collaborations highlight his commitment to improving patient outcomes through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…